Hans Askelund Saevereid

Hans Askelund Saevereid

Novo Nordisk A S - Bagsvaerd / Denmark
Medical and Health Sciences / Cardiology
AD Scientific Index ID: 5286094
person_outline Hans Askelund Saevereid's MOST POPULAR ARTICLES
1-) Speed and duration of walking and other leisure time physical activity and the risk of heart failure: a prospective cohort study from the Copenhagen City Heart Study HA Saevereid, P Schnohr, E Prescott PLoS One 9 (3), e89909, 2014 452014
2-) Effects of liraglutide on cardiovascular outcomes in type 2 diabetes patients with and without baseline metformin use: post hoc analyses of the LEADER trial MJ Crowley, DK McGuire, AS Alexopoulos, TJ Jensen, S Rasmussen, ... Diabetes Care 43 (9), e108, 2020 412020
3-) Effects of liraglutide compared with placebo on events of acute gallbladder or biliary disease in patients with type 2 diabetes at high risk for cardiovascular events in the … MA Nauck, ML Muus Ghorbani, E Kreiner, HA Saevereid, JB Buse, ... Diabetes Care 42 (10), 1912-1920, 2019 342019
4-) LEADER Publication Committee on behalf of the LEADER Trial Investigators. Effects of liraglutide compared with placebo on events of acute gallbladder or biliary disease in …MA Nauck, ML Muus Ghorbani, E Kreiner, HA Saevereid, JB BuseDiabetes Care 42 (10), 1912-1920, 2019352019
5-) Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trialsS Verma, SC Bain, T Monk Fries, CD Mazer, MA Nauck, RE Pratley, ...Diabetes, Obesity and Metabolism 21 (7), 1745-1751, 2019342019